ArticleAdvances in therapy2023

Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States.

Jesse A Sussell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.